Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effect of 37℃ Non-ionic Contrast Agent During ERCP Procedure in Hilar Cholangiocarcinoma
Sponsor: Hepatopancreatobiliary Surgery Institute of Gansu Province
Summary
The purpose of this study is to determine the effect of normal temperature and 37℃ non-ionic contrast agent acting on ERCP-related cholangeitis after endoscopic retrograde cholangiopancreatography (ERCP) in the treatment of hilar cholangiocarcinoma.
Official title: Effect of 37℃ Non-ionic Contrast Agent During ERCP Procedure in Hilar Cholangiocarcinoma: A Prospective Double-blind Multicenter Randomized Controlled Study
Key Details
Gender
All
Age Range
18 Years - 90 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2026-04-01
Completion Date
2028-12-01
Last Updated
2025-12-26
Healthy Volunteers
No
Conditions
Interventions
Injection of 37℃ contrast agent
Nonionic contrast agent is heated to 37℃ in a incubator when injection of contrast agent
Locations (3)
The first hospital of Lanzhou university
Lanzhou, Gansu, China
The first affiliated hospital of Xi 'an jiaotong university
Xi'an, Shaanxi, China
Tianjin Nankai Hospital
Tianjin, Tianjin Municipality, China